PURPOSE: This study aimed to present real-life data on the use, effectiveness, and safety of administering Ceftolozane/Tazobactam (C/T) through elastomeric pumps (EP) in the outpatient setting. METHODS: elastomeric pumps. RESULTS: = 2/7; 29%). CONCLUSIONS: especially for multidrug-resistant strains.